Pediatric Neurology Division, Department of Pediatrics, All India Institute of Medical Sciences, Rishikesh, India.
Department of Neurology, IQRAA International Hospital & Research Centre, Kozhikode, Kerala, India.
Am J Trop Med Hyg. 2022 Aug 29;107(4):833-840. doi: 10.4269/ajtmh.21-1298. Print 2022 Oct 12.
Inflammatory granulomas (neurocysticercosis [NCC] and tuberculomas) are important causes of seizures in children and adults in the developing world. Although several studies have explored seizure characteristics individually in patients with either NCC or tuberculoma, none has compared the seizure recurrence rate between them. This study included patients aged 5 to 18 years with viable parenchymal NCC or tuberculomas who had completed regular follow-up of at least 12 months at a tertiary institute in India. Their baseline seizure and electroencephalographic characteristics, antiseizure medications (ASMs), and breakthrough seizure rates at 12, 24, and 52 weeks were noted. A total of 103 and 54 patients with active NCC and tuberculomas respectively were included. The number of patients who had at least one breakthrough seizure at 12, 24, and 52 weeks in both groups was comparable (P = 0.32, 0.27, and 0.13), and the vast majority were controlled on monotherapy (98% cases in each group). The proportion of patients who required an increase in the dose or change of ASMs or polytherapy, the proportion of children who had status epilepticus at or before 12 months, abnormal electroencephalogram at 12 months, and calcified and active granuloma in neuroimaging at 12 months were also comparable between the two groups (P > 0.05 for all). The number of patients who had ASM-related adverse events and discontinued ASM due to serious adverse events was comparable between both groups, except for hepatotoxicity in the tuberculoma group. The predictors for breakthrough seizures that were found to be statistically significant in the NCC group were the presence of perilesional edema in the baseline magnetic resonance imaging (P = 0.02) and more than five active granulomas (P = 0.01); predictors in the tuberculoma group were the presence of severe perilesional edema causing midline shift in the baseline magnetic resonance imaging (P = 0.01) and more than five active granulomas (P = 0.04). The recurrence rates of breakthrough seizures over the next 12 months in newly detected cases of active NCC and tuberculomas were comparable.
炎性肉芽肿(神经囊尾蚴病[NCC]和结核瘤)是发展中国家儿童和成人癫痫发作的重要原因。尽管有几项研究分别探讨了 NCC 或结核瘤患者的癫痫发作特征,但没有一项研究比较它们之间的癫痫复发率。本研究纳入了在印度一家三级医院接受至少 12 个月定期随访的年龄在 5 至 18 岁之间、有活动期脑实质 NCC 或结核瘤的患者。记录了他们的基线癫痫发作和脑电图特征、抗癫痫药物(ASM)以及 12、24 和 52 周时的突破性癫痫发作率。分别有 103 例和 54 例活动期 NCC 和结核瘤患者符合纳入标准。两组在 12、24 和 52 周时至少有一次突破性癫痫发作的患者数量相当(P=0.32、0.27 和 0.13),并且绝大多数患者接受单药治疗即可控制(每组 98%的病例)。需要增加剂量或更换 ASM 或联合治疗的患者比例、在 12 个月时或之前发生癫痫持续状态的儿童比例、12 个月时脑电图异常以及 12 个月时神经影像学上钙化和活动性肉芽肿的比例在两组之间也相当(所有 P 值>0.05)。两组之间因严重不良反应而停用 ASM 的患者比例以及出现 ASM 相关不良反应的患者比例也相当,除了结核瘤组的肝毒性。在 NCC 组中,发现与突破性癫痫发作相关的统计学显著预测因子是基线磁共振成像上的病灶周围水肿(P=0.02)和超过 5 个活动性肉芽肿(P=0.01);在结核瘤组中,预测因子是基线磁共振成像上严重的病灶周围水肿导致中线移位(P=0.01)和超过 5 个活动性肉芽肿(P=0.04)。在接下来的 12 个月中,新发现的活动性 NCC 和结核瘤患者的突破性癫痫发作复发率相当。